— Published date: 7/28/2026
Value Proposition: Synergistic combination of intratumoral oncolytic therapy and MEK inhibition for treating metastatic melanoma.
Technology Description
Researchers at Washington University in St. Louis have developed a highly effective combination therapy using two …
— Published date: 7/22/2026
Value Proposition: New process that tackles two RA signaling pathways to improve treatment of various diseases.
Technology Description
Researchers at Washington University in St. Louis have uncovered an antagonistic interaction between estrogen and retinoic acid (RA) …
— Published date: 7/7/2026
Value Proposition: Novel covalent dimerization of UvrD helicase that enhances DNA unwinding processivity and isothermal polymerase chain reaction.
Technology Description
Researchers at Washington University in St. Louis have developed a modified Superfamily 1A helicase …
— Published Date: 7/7/2026
Value Proposition: This invention introduces a mucosal vaccine that can provide immunity against multiple Sarbecoviruses.
Technology Description
Researchers at Washington University in St. Louis have developed an adenoviral-vectored vaccine that can induce broad immunity…
— Published date: 6/2/2026
Value proposition: CAR-engineered cDC1 cells (syngeneic or allogeneic) that stably express a proprietary, modular chimeric antigen receptor and demonstrate strong in vivo efficacy against solid tumors, including immunologically ‘cold’ tumors.
Technology Desc…
| Name | # Summaries | Author | Action |
|---|---|---|---|
| 15 | |||
| 13 | |||
| 1 | |||
| 15 | |||
| 26 | |||
| 14 | |||
| 14 |
Creating...
